How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PBM ACCOUNTABILITY PROJECT via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding Pharmaceutical Benefit Manager reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Source: Senate LDA
| GENENTECH | 6 | 2025–2026 |
| IPSEN BIOPHARMACEUTICALS, INC. | 6 | 2025–2026 |
| LUNDBECK PHARMACEUTICALS, LLC | 6 | 2025–2026 |
| NATIONAL ASSOCIATION OF REALTORS | 6 | 2025–2026 |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 6 | 2025–2026 |
| SANTANDER HOLDINGS USA, INC. | 6 | 2025–2026 |
| ZAI LAB (US) LLC | 6 | 2025–2026 |
| ADP LLC | 5 | 2025–2026 |
| AMERICAN ACADEMY OF DERMATOLOGY | 5 | 2025–2026 |
| AMERICAN ACADEMY OF OPHTHALMOLOGY | 5 | 2025–2026 |
| COUNCIL OF THE DISTRICT OF COLUMBIA | 5 | 2026 |
| LENOVO (UNITED STATES) INC. | 5 | 2025–2026 |
| NATIONAL COUNCIL OF NONPROFITS | 5 | 2025–2026 |
| NEUROCRINE BIOSCIENCES, INC | 5 | 2025–2026 |
| PBM ACCOUNTABILITY PROJECT | 5 | 2025–2026 |
| TEMPUS LABS INC | 5 | 2025–2026 |
| CONTINUUS PHARMACEUTICALS | 4 | 2025–2026 |
| MADRIGAL PHARMACEUTICALS, INC. | 4 | 2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 4 | 2025–2026 |
| AMGEN, INC. | 3 | 2026 |
| BRISTOL-MYERS SQUIBB | 3 | 2026 |
| CAPITAL ONE FINANCIAL CORP. | 3 | 2026 |
| GLAXOSMITHKLINE LLC | 3 | 2026 |
| GRANICUS, LLC | 3 | 2026 |
| PCCA, INC. | 3 | 2025–2026 |
| AMERICAN HEALTH CARE ASSOCIATION | 2 | 2025 |
| AMICUS THERAPEUTICS, INC. | 2 | 2026 |
| DISC MEDICINE | 2 | 2026 |
| REMITLY, INC. | 1 | 2025 |
| UMPQUA BANK | 1 | 2025 |
Disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026.
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Ensuring Community Access to Pharmacist Services Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Ensuring Community Access to Pharmacist Services Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
D. C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
D. C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
D. C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
D. C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
D. C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Make the District of Columbia Safe and Beautiful Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Make the District of Columbia Safe and Beautiful Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Make the District of Columbia Safe and Beautiful Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Make the District of Columbia Safe and Beautiful Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Make the District of Columbia Safe and Beautiful Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Common-Sense Law Enforcement and Accountability Now in DC Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Common-Sense Law Enforcement and Accountability Now in DC Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Common-Sense Law Enforcement and Accountability Now in DC Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Common-Sense Law Enforcement and Accountability Now in DC Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Common-Sense Law Enforcement and Accountability Now in DC Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
District of Columbia Attorney General Appointment Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
District of Columbia Attorney General Appointment Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
District of Columbia Attorney General Appointment Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
District of Columbia Attorney General Appointment Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
District of Columbia Attorney General Appointment Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
District of Columbia Cash Bail Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
District of Columbia Cash Bail Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
District of Columbia Cash Bail Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
District of Columbia Cash Bail Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
District of Columbia Cash Bail Reform Act of 2025
Client: COUNCIL OF THE DISTRICT OF COLUMBIA · Firm: CAPITOL COUNSEL LLC
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Physical Therapist Workforce and Patient Access Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Physical Therapist Workforce and Patient Access Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Physical Therapist Workforce and Patient Access Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
To amend the Internal Revenue Code of 1986 to terminate the tax-exempt status of terrorist supporting organizations.
Client: NATIONAL COUNCIL OF NONPROFITS · Firm: CAPITOL COUNSEL LLC
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
To amend the Internal Revenue Code of 1986 to terminate the tax-exempt status of terrorist supporting organizations.
Client: NATIONAL COUNCIL OF NONPROFITS · Firm: CAPITOL COUNSEL LLC
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
Consolidated Appropriations Act, 2026
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Consolidated Appropriations Act, 2026
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Stopping Fraudulent Payments Act
Client: NATIONAL COUNCIL OF NONPROFITS · Firm: CAPITOL COUNSEL LLC
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including H.R. 8464 Stopping Fraudulent Payments Act, and OMB's proposed rule for Guidance for Federal Financial Assistance (OMB-2026-0034).
Stopping Fraudulent Payments Act
Client: NATIONAL COUNCIL OF NONPROFITS · Firm: CAPITOL COUNSEL LLC
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including H.R. 8464 Stopping Fraudulent Payments Act, and OMB's proposed rule for Guidance for Federal Financial Assistance (OMB-2026-0034).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
A bill to amend the Internal Revenue Code of 1986 to terminate the tax-exempt status of terrorist supporting organizations.
Client: NATIONAL COUNCIL OF NONPROFITS · Firm: CAPITOL COUNSEL LLC
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
A bill to amend the Internal Revenue Code of 1986 to terminate the tax-exempt status of terrorist supporting organizations.
Client: NATIONAL COUNCIL OF NONPROFITS · Firm: CAPITOL COUNSEL LLC
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Bipartisan Health Care Act
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Bipartisan Health Care Act
Client: AMERICAN ACADEMY OF OPHTHALMOLOGY · Firm: CAPITOL COUNSEL LLC
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Issues regarding approved and pipeline products, and related policy. FDA Clinical Trial reform proposals.
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Issues regarding approved and pipeline products, and related policy. IRA price negotiation. MFN proposals, including GLOBE and GUARD and impacts on innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL OF THE DISTRICT OF COLUMBIA via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Legislative issues related to Medicare Part B.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COUNCIL OF THE DISTRICT OF COLUMBIA via CAPITOL COUNSEL LLC
2026 · second_quarter · 2A
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL OF THE DISTRICT OF COLUMBIA via CAPITOL COUNSEL LLC
2026 · first_quarter · 1A
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSEN BIOPHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitoring implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
340B Program issues and patient access to pharmaceuticals. Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.
Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives.
AMGEN INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN BANKERS ASSOCIATION HSA COUNCIL via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to Health Savings Accounts.
Issues related to Health Savings Accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF OPHTHALMOLOGY via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
AMERICAN ACADEMY OF DERMATOLOGY via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer.
Tax on indoor tanning services.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
LENOVO (UNITED STATES) INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Advocacy before Congress and the Executive branch on procurement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL OF NONPROFITS via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including H.R. 8464 Stopping Fraudulent Payments Act, and OMB's proposed rule for Guidance for Federal Financial Assistance (OMB-2026-0034).
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
NEUROCRINE BIOSCIENCES, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
GLAXOSMITHKLINE LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AMBULANCE ASSOCIATION via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding fuel tax relief.
Issues regarding extension of Medicare Add-on Payments, workforce shortages, balance billing comprehensive payment reform, and Medicare Advantage payment levels
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAI LAB (US) LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Legislative and regulatory issues related to independent pharmacists. PBM reform, including implementation of Public Law No. 119-75. DoD / TRICARE pharmacy benefit program audit.
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUNDBECK PHARMACEUTICALS LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRANICUS, LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Supporting administration efforts to communicate with constituents utilizing GovDelivery.
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
Filing targets: Agriculture, Dept of (USDA), Energy, Dept of, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Treasury, Dept of, White House Office
AMERICAN PHYSICAL THERAPY ASSOCIATION via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Non-Compete agreement restrictions.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
SANTANDER HOLDINGS USA, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to Basel Capital Standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF REALTORS via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to housing, financial services, and flood insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITAL ONE FINANCIAL CORP. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
General monitoring of tax-related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Monitoring tax-related issues, including the Work Opportunity Tax Credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL OF THE DISTRICT OF COLUMBIA via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act, S. J. Res 194/H.J.Res. 193, joint resolutions disapproving the action of the District of Columbia Council in approving the Body-Worn Camera Transparency for Use of Force Temporary Amendment Act of 2026, and S.J.Res, 195/H.J.Res. 192, joint resolutions disapproving the action of the District of Columbia Council in approving the Full Accountability in Arrest Reporting Temporary Amendment Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative issues related to Medicare Part B.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF REALTORS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues related to housing, financial services, and flood insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITAL ONE FINANCIAL CORP. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
General monitoring of tax-related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PBM ACCOUNTABILITY PROJECT via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding Pharmaceutical Benefit Manager reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AMBULANCE ASSOCIATION via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding extension of Medicare Add-on Payments, workforce shortages, balance billing comprehensive payment reform, and Medicare Advantage payment levels
Issues regarding fuel tax relief.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSEN BIOPHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitoring implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives.
340B Program issues and patient access to pharmaceuticals. Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN BANKERS ASSOCIATION HSA COUNCIL via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues related to Health Savings Accounts.
Issues related to Health Savings Accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF OPHTHALMOLOGY via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative issues relating to vision care within the VA Health System.
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
AMERICAN ACADEMY OF DERMATOLOGY via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer.
ZAI LAB (US) LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative and regulatory issues related to independent pharmacists. PBM reform, including implementation of Public Law No. 119-75
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUNDBECK PHARMACEUTICALS LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRANICUS, LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
Supporting administration efforts to communicate with constituents utilizing GovDelivery.
Filing targets: Agriculture, Dept of (USDA), Energy, Dept of, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Treasury, Dept of
DISC MEDICINE via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Engagement with Congress regarding FDA approvals for rare diseases.
Engagement with Congress regarding FDA approvals for rare diseases.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CONTINUUS PHARMACEUTICALS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding incentives to rehore pharmaceutical manufacturing.
Issues regarding incentives to reshore pharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding approved and pipeline products, and related policy.
Issues regarding approved and pipeline products, and related policy.
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · 2T
Legislative and regulatory issues affecting SMID rare disease biotech companies.
Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PHYSICAL THERAPY ASSOCIATION via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANTANDER HOLDINGS USA, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues related to Basel Capital Standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
GLAXOSMITHKLINE LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL OF NONPROFITS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including H.R. 8464 Stopping Fraudulent Payments Act, and OMB's proposed rule for Guidance for Federal Financial Assistance (OMB-2026-0034).
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status, including S. 3554/ H.R. 6800 and S. 3942/ H.R. 7799 SPONSOR Act.
LENOVO (UNITED STATES) INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Advocacy before Congress and the Executive branch on procurement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Monitoring tax-related issues, including the Work Opportunity Tax Credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRANICUS, LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · RR
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
COUNCIL OF THE DISTRICT OF COLUMBIA via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative issues related to Medicare Part B.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding approved and pipeline products, and related policy.
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Issues regarding approved and pipeline products, and related policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITAL ONE FINANCIAL CORP. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
General monitoring of tax-related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AMBULANCE ASSOCIATION via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding extension of Medicare Add-on Payments, workforce shortages, balance billing and surprise medical billing reform.
Issues regarding fuel tax relief.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF OPHTHALMOLOGY via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Ophthalmologists' services in Department of Veterans Affairs programs. Monitor implementation of Surprise Medical Billing law. Advocacy on Risk Evaluation and Mitigation Strategy (REMS) issues. Monitor legislative action on healthcare workforce issues.
Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.
AMERICAN ACADEMY OF DERMATOLOGY via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Tax on indoor tanning services.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LENOVO (UNITED STATES) INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Advocacy before Congress and the Executive branch on procurement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSEN BIOPHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
340B Program issues and patient access to pharmaceuticals. Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.
Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives.
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ZAI LAB (US) LLC via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PCCA, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · 1T
Issues regarding drug compounding of generic drugs in shortage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Legislative and regulatory issues related to independent pharmacists. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act. H.R./S._Lower Costs, More Transparency Act.
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
FDA and regulatory issues related to the biopharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMICUS THERAPEUTICS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.
Legislative and regulatory issues affecting SMID rare disease biotech companies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION HSA COUNCIL via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues related to Health Savings Accounts.
Issues related to Health Savings Accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PBM ACCOUNTABILITY PROJECT via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding Pharmaceutical Benefit Manager reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL OF NONPROFITS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUNDBECK PHARMACEUTICALS LLC via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISC MEDICINE via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Engagement with Congress regarding FDA approvals for rare diseases.
Engagement with Congress regarding FDA approvals for rare diseases.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CONTINUUS PHARMACEUTICALS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding incentives to reshore pharmaceutical manufacturing.
Issues regarding incentives to rehore pharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PHYSICAL THERAPY ASSOCIATION via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
NEUROCRINE BIOSCIENCES, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
GLAXOSMITHKLINE LLC via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SANTANDER HOLDINGS USA, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues related to Basel Capital Standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF REALTORS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues related to housing, financial services, and flood insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Monitoring tax-related issues, including the Work Opportunity Tax Credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · RR
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry.
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2025 · third_quarter · 3A
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL OF NONPROFITS via CAPITOL COUNSEL LLC
2025 · fourth_quarter · Q4
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Issues regarding freedom of religion, philanthropy, and speech as they pertain to nonprofits' missions and protecting their tax-exempt status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AMBULANCE ASSOCIATION via CAPITOL COUNSEL LLC
2025 · fourth_quarter · Q4
Issues regarding extension of Medicare Add-on Payments, workforce shortages, balance billing and surprise medical billing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Ophthalmologists' services in Department of Veterans Affairs programs. Monitor implementation of Surprise Medical Billing law. Advocacy on Risk Evaluation and Mitigation Strategy (REMS) issues. Monitor legislative action on healthcare workforce issues.
Legislative issues relating to vision care within the VA Health System.
Issues related to implementation of legislative provisions of the Labor-HHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Ophthalmologists' services in Department of Veterans Affairs programs. Monitor implementation of Surprise Medical Billing law. Advocacy on Risk Evaluation and Mitigation Strategy (REMS) issues. Monitor legislative action on healthcare workforce issues.
Issues related to implementation of legislative provisions of the Labor-HHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Tax on indoor tanning services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative issues relating to vision care within the VA Health System.
Issues related to implementation of legislative provisions of the Labor-HHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE